Quest Diagnostics Incorporated (LON:0KSX)
180.54
-1.68 (-0.92%)
At close: Oct 23, 2025
Quest Diagnostics Revenue
Quest Diagnostics had revenue of $2.82B USD in the quarter ending September 30, 2025, with 13.18% growth. This brings the company's revenue in the last twelve months to $10.85B, up 13.74% year-over-year. In the year 2024, Quest Diagnostics had annual revenue of $9.87B with 6.70% growth.
Revenue (ttm)
$10.85B
Revenue Growth
+13.74%
P/S Ratio
1.89
Revenue / Employee
$193.75K
Employees
56,000
Market Cap
15.23B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.87B | 620.00M | 6.70% |
| Dec 31, 2023 | 9.25B | -631.00M | -6.38% |
| Dec 31, 2022 | 9.88B | -905.00M | -8.39% |
| Dec 31, 2021 | 10.79B | 1.35B | 14.32% |
| Dec 31, 2020 | 9.44B | 1.71B | 22.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Quest Diagnostics News
- 8 days ago - Mizuho Raises Price Target for Quest Diagnostics (DGX) to $210 | DGX Stock News - GuruFocus
- 11 days ago - Will Quest Diagnostics (DGX) Beat Estimates Again in Its Next Earnings Report? - Nasdaq
- 11 days ago - Quest Diagnostics (DGX) Reports Next Week: Wall Street Expects Earnings Growth - Nasdaq
- 11 days ago - Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings - Nasdaq
- 17 days ago - Evercore ISI Group Raises Price Target for Quest Diagnostics (DGX) to $190 | DGX Stock News - GuruFocus
- 19 days ago - Quest Diagnostics: Investing In Healthcare's Future Today - Seeking Alpha
- 22 days ago - Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term - Nasdaq
- 23 days ago - Barclays Raises Price Target for Quest Diagnostics (DGX) to $190 | DGX Stock News - GuruFocus